Chemotherapy is still given to a minority of patients as part of their end-of-life care despite concerns about the risk of toxicity and hospitalisation that can impact quality of life, Australian research shows. A retrospective analysis of data from the Queensland Oncology Repository found about 9% of patients with lung cancer and about 12% of ...
End-of-life chemo risks unwanted deaths in hospital
By Mardi Chapman
21 Oct 2020